fda drug shortage list tirzepatide GLP-1 Drugs: Removes Lilly's Zepbound® and Mounjaro® (tirzepatide injection) from its Drug Shortages | FDA
Description
Teva Pharmaceuticals has launched the first generic version of Saxenda, effectively ending Novo Nordisk monopoly in GLP-1based obesity therapies
HPA axis dysfunction is what happens when we are under a tremendous amount of stress

In a more recent trial of exenatide in PD, disease modifying effects measured by nigrostriatal dopamine transporter imaging (DaTscan) were reported (Athauda et al

This implied that the effect of cortisol on blood glucose was closely allied to its circadian rhythm

To our knowledge, no study assessed the potential of abuse of these medications anecdotally reported in anorexia or bulimia nervosa, which would require further investigation
PlexusDx compounded semaglutide injections start at $149 per month and remain flat regardless of dose escalation
